Comer S D, Hart C L, Ward A S, Haney M, Foltin R W, Fischman M W
Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA.
Psychopharmacology (Berl). 2001 Jun;155(4):397-404. doi: 10.1007/s002130100727.
Although methamphetamine use has increased over the past several years, few studies have evaluated the effects of repeated methamphetamine administration in humans.
Because methamphetamine is often taken in a pattern of repeated use followed by a period of abstinence, the present study sought to evaluate the effects of repeated methamphetamine administration in humans. The hypothesis was that tolerance would develop to methamphetamine's effects.
Seven normal, healthy volunteers participated in a 15-day residential study. Participants completed subjective-effects questionnaires and psychomotor performance tasks repeatedly throughout the experimental day. Oral methamphetamine (5, 10 mg BID) was administered on days 4-6 and 10-12; placebo was administered on all other study days.
Relative to placebo baseline, only two "positive" subjective ratings ("I feel a good drug effect" and "I feel high") were significantly elevated, and only on the 1st day of methamphetamine administration. In contrast, numerous "negative" ratings, including "I feel..." "a bad drug effect," "dizzy," and "flu-like symptoms" were elevated on the 3rd day of methamphetamine administration. Total caloric intake decreased and sleep was disrupted after methamphetamine administration, relative to baseline.
The pattern of methamphetamine's positive subjective effects were altered with chronic administration such that tolerance, or a decreased effect, occurred after repeated administration. In contrast, methamphetamine's negative subjective effects increased over days. These results suggest that in this population of normal volunteers, the abuse liability of oral methamphetamine is relatively low.
尽管在过去几年中甲基苯丙胺的使用有所增加,但很少有研究评估反复使用甲基苯丙胺对人体的影响。
由于甲基苯丙胺的使用模式通常是反复使用一段时间后再 abstinence一段时间,本研究旨在评估反复使用甲基苯丙胺对人体的影响。假设是对甲基苯丙胺的作用会产生耐受性。
七名正常、健康的志愿者参加了一项为期15天的住院研究。参与者在整个实验日反复完成主观效应问卷和心理运动表现任务。在第4至6天和第10至12天口服甲基苯丙胺(5、10毫克,每日两次);在所有其他研究日给予安慰剂。
相对于安慰剂基线,只有两项“积极”主观评分(“我感觉药物效果良好”和“我感觉兴奋”)显著升高,且仅在甲基苯丙胺给药的第1天。相比之下,许多“消极”评分,包括“我感觉……”“药物效果不佳”、“头晕”和“流感样症状”在甲基苯丙胺给药的第3天升高。与基线相比,甲基苯丙胺给药后总热量摄入减少,睡眠受到干扰。
甲基苯丙胺的积极主观效应模式随着长期给药而改变,反复给药后出现耐受性或效应降低。相比之下,甲基苯丙胺的消极主观效应在数天内增加。这些结果表明,在这群正常志愿者中,口服甲基苯丙胺的滥用可能性相对较低。